ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

23,403Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 14

$1.22M Total Retail Price of All Prescriptions

Rank: 2 out of 14

551 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
55% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kansas
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 551 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

23% of this provider’s 551 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 19,696 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

42 is the average number of prescriptions (including refills) per patient, compared to an average of 31.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kansas
LEVOTHYROXINE SODIUM 1,030 945 1 1
FUROSEMIDE 922 831 2 3
HYDROCODONE-ACETAMINOPHEN 836 739 S3 3 2
SIMVASTATIN 635 517 4 5
LISINOPRIL 595 488 5 4
POTASSIUM CHLORIDE 516 460 6 12
WARFARIN SODIUM 504 466 7 9
GABAPENTIN 481 387 8 11
NAMENDA 398 398 9 10
MIRTAZAPINE 397 393 10 13
EXELON 373 368 11 33
OMEPRAZOLE 372 324 12 7
AMLODIPINE BESYLATE 355 333 13 6
SERTRALINE HCL 335 269 14 19
ATENOLOL 310 283 15 28
DONEPEZIL HCL 309 309 16 8
LOSARTAN POTASSIUM 273 247 17 21
POLYETHYLENE GLYCOL 3350 272 250 18 29
FAMOTIDINE 270 251 19 36
METOPROLOL TARTRATE 266 229 20 15
RANITIDINE HCL 260 229 21 48
KLOR-CON M20 252 207 22 30
ALENDRONATE SODIUM 245 215 23 27
SPIRONOLACTONE 243 191 24 49
METFORMIN HCL 232 169 25 20
PANTOPRAZOLE SODIUM 229 210 26 47
FENTANYL 206 162 S2 27 42
TRAZODONE HCL 199 141 28 39
CYMBALTA 183 142 29 32
NOVOLOG 181 136 30 22
TAMSULOSIN HCL 176 151 31 31
ESCITALOPRAM OXALATE 175 142 32 52
ALBUTEROL SULFATE 166 160 33 44
ZOLPIDEM TARTRATE 165 111 34 37
CIPROFLOXACIN HCL 162 134 35 53
JANTOVEN 161 161 36 18
ALLOPURINOL 160 151 37 46
LANTUS 159 131 38 23
PREDNISONE 152 137 39 63
METOPROLOL SUCCINATE 151 120 40 35
AZITHROMYCIN 150 131 41 69
METHENAMINE HIPPURATE 143 125 42 83
HYDROCHLOROTHIAZIDE 139 127 43 24
DIGOXIN 136 110 44 34
ATORVASTATIN CALCIUM 136 125 44 25
CLOTRIMAZOLE-BETAMETHASONE 130 95 46 150
CITALOPRAM HBR 128 92 47 14
RISPERIDONE 126 83 48 38
DIVALPROEX SODIUM 120 74 49 40
TRAMADOL HCL-ACETAMINOPHEN 120 110 49 158
CARBIDOPA-LEVODOPA 119 119 51 51
OXYCODONE HCL-ACETAMINOPHEN 117 0 S2 52 68
DIVALPROEX SODIUM ER 116 89 53 61
ROPINIROLE HCL 108 86 54 57
CLOPIDOGREL 107 91 55 43
CARVEDILOL 107 84 55 17
IPRATROPIUM-ALBUTEROL 106 93 57 66
LEVETIRACETAM 105 65 58 72
GLYBURIDE 96 93 R 59 91
SUCRALFATE 93 80 60 132
SULFAMETHOXAZOLE-TRIMETHOPRIM 93 75 60 78
PHENYTOIN SODIUM EXTENDED 90 80 62 86
BACLOFEN 87 52 63 82
FINASTERIDE 86 80 64 67
DILTIAZEM ER 81 81 65 96
PLAVIX 80 62 66 65
JANUVIA 79 67 67 104
BUSPIRONE HCL 78 77 68 61
LEXAPRO 78 66 68 119
FLUTICASONE PROPIONATE 77 57 70 56
SPIRONOLACTONE-HCTZ 77 62 70 189
TOPIRAMATE 77 53 70 134
LEVOFLOXACIN 75 55 73 88
MINOCYCLINE HCL 75 64 73 150
QUETIAPINE FUMARATE 75 54 73 26
SINGULAIR 73 55 76 195
KLOR-CON M10 72 51 77 50
PAROXETINE HCL 72 67 77 86
PRAVASTATIN SODIUM 71 67 79 74
METOLAZONE 71 65 79 113
PRAMIPEXOLE DIHYDROCHLORIDE 71 71 79 149
ABILIFY 69 53 82 99
LYRICA 69 11 82 80
NEXIUM 68 65 84 95
PROCHLORPERAZINE MALEATE 68 57 84 203
HYDRALAZINE HCL 68 57 84 89
GLIMEPIRIDE 68 57 84 103
GEMFIBROZIL 67 55 88 139
AMOX TR-POTASSIUM CLAVULANATE 67 60 88 205
NYSTATIN 65 54 90 106
OXYBUTYNIN CHLORIDE ER 65 46 90 96
ISOSORBIDE MONONITRATE ER 64 50 92 71
DILTIAZEM 24HR CD 64 64 92 90
LIDODERM 63 54 94 79
ESTRADIOL 60 55 R 95 217
CEPHALEXIN 59 52 96 77
ACTOS 58 54 97 221
PROAIR HFA 58 51 97 112
OLANZAPINE 58 41 97 100
METHOCARBAMOL 57 40 R 100 223
PRIMIDONE 57 47 100 223
SODIUM CHLORIDE 57 25 100 223
VESICARE 56 56 103 94
LEVEMIR 55 39 104 135
DILTIAZEM 24HR ER 55 55 104 161
METOCLOPRAMIDE HCL 54 51 106 123
SEROQUEL 54 40 106 64
TRAMADOL HCL 51 41 108 16
NITROFURANTOIN 51 41 108 241
CLONIDINE HCL 50 38 110 54
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 2, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.